AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 59 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $139,839 | +29.5% | 10,305 | +63.7% | 0.00% | – |
Q2 2023 | $107,976 | -59.8% | 6,296 | -52.7% | 0.00% | – |
Q1 2023 | $268,303 | +21.2% | 13,302 | +76.0% | 0.00% | – |
Q4 2022 | $221,391 | +4.9% | 7,556 | -40.6% | 0.00% | – |
Q3 2022 | $211,000 | +559.4% | 12,727 | +526.6% | 0.00% | – |
Q2 2022 | $32,000 | -57.3% | 2,031 | -50.5% | 0.00% | – |
Q1 2022 | $75,000 | -33.0% | 4,103 | -56.9% | 0.00% | – |
Q4 2021 | $112,000 | +522.2% | 9,515 | +980.0% | 0.00% | – |
Q3 2021 | $18,000 | – | 881 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 603,762 | $8,193,050 | 18.42% |
TCG Crossover Management, LLC | 2,201,274 | $29,871,288 | 4.40% |
Atlas Venture Life Science Advisors, LLC | 2,039,249 | $27,672,609 | 4.29% |
Sofinnova Investments, Inc. | 3,758,686 | $51,005,369 | 3.22% |
GREAT POINT PARTNERS LLC | 1,091,233 | $14,808,032 | 2.70% |
RA Capital Management | 8,263,982 | $112,142,236 | 2.21% |
Cormorant Asset Management, LP | 1,561,696 | $21,192,215 | 1.24% |
Frazier Life Sciences Management, L.P. | 1,204,867 | $16,350,045 | 1.09% |
Octagon Capital Advisors LP | 497,370 | $6,749,311 | 1.04% |
Ghost Tree Capital, LLC | 201,197 | $2,730,243 | 0.90% |